Pulmonary Parenchymal Changes in COVID-19 Survivors

Area of Science:

• Pulmonary Medicine
• Pathology
• Infectious Diseases

Background:

• The long-term effects of COVID-19 on lung health remain a significant concern during the survivorship phase.
• Existing histopathologic data primarily comes from autopsy reports, limiting understanding of survivors' lung changes.
• This study investigates post-acute histopathologic alterations in the lungs of COVID-19 survivors.

Purpose of the Study:

• To determine if COVID-19 survivors exhibit distinct histopathologic changes in their lung parenchyma after recovery.
• To compare lung tissue from COVID-19 survivors with that of individuals who never had COVID-19 and those with end-stage disease.

Main Methods:

• A multicenter observational study included 11 adult COVID-19 survivors undergoing elective lung resection.
• Lung specimens were compared to age- and procedure-matched controls (n=5) and an end-stage COVID-19 group (n=3).
• A blinded pulmonary pathologist analyzed lung parenchyma across airways, alveoli, interstitium, and vasculature.

Main Results:

• No significant differences in lung parenchyma histopathology were observed between COVID-19 survivors and controls across all examined compartments.
• Patients with end-stage COVID-19 displayed fibrotic diffuse alveolar damage, intra-alveolar macrophages, organizing pneumonia, and interstitial emphysema.
• Lung resections were performed a median of 68.5 days post-diagnosis in survivors with asymptomatic, moderate, or severe COVID-19.

Conclusions:

• This study found no distinct post-acute histopathologic changes suggesting permanent pulmonary damage in COVID-19 survivors.
• The findings are reassuring for individuals recovering from COVID-19, particularly those who become asymptomatic.
• Further research may explore subtle or functional changes not detectable by standard histopathology.